Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CRON vs SIGA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRON Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

CRON Overall Winner 6-Pillar Tally: CRON 5 – 1 SIGA Matrix Metrics: CRON 9 – 1 SIGA

As of Nov 20, 2026, Cronos Group Inc. Common Share (CRON) is the stronger overall head-to-head candidate over SIGA Technologies Inc. (SIGA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CRON carries a Unified Composite Score of 53.4/100 (HOLD) at $3.04 (12.0x Forward P/E, 6.1% operating margin), whereas SIGA carries 46.2/100 (HOLD) at $2.40 (2.3x Forward P/E, -14.2% operating margin).

  • Technical & Structure Timing Caution: CRON trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 33.9); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRON vs SIGA
CRON NASDAQ Head-to-Head Winner
Cronos Group Inc. Common Share
Medicinal Chemicals & Botanical Products
$3.04
-1.3% 1D
Market Cap $1.1B
TTM Revenue $206M
Forward P/E 12.0x
Beta / 30D Vol 0.36β · 38% Vol
Unified Composite Score
53.4 / 100 HOLD
Tech 27.0 Fund 47.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 34
RSI-14: 33.9 · SMA20: $3.36 · SMA50: $3.32
SIGA NASDAQ
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.40
-9.43% 1D
Market Cap $188.3M
TTM Revenue $52M
Forward P/E 2.3x
Beta / 30D Vol 0.90β · 74% Vol
Unified Composite Score
46.2 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 68.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.2%), weak momentum, RSI 31
RSI-14: 31.0 · SMA20: $2.99 · SMA50: $3.13

6-Pillar Scorecard Institutional Category Breakdown (CRON 5 – 1 SIGA)

Columns: Metric · CRON · SIGA
1. Valuation Multiples SIGA
Forward P/E 12.0x 2.3x
Trailing P/E 19.2x N/M
PEG Ratio N/M 3.37x
EV / Revenue 3.5x 1.4x
2. Growth & Scale CRON
Revenue Growth (YoY) +74.6% -49.7%
Earnings Growth (YoY) -44.7% -65.3%
TTM Revenue (USD) $206M $52M
Market Cap $1.1B $188.3M
3. Profitability & Quality CRON
Gross Margin 46.3% 23.4%
Operating Margin 6.1% -14.2%
Net Profit Margin 28.0% 1.3%
Return on Equity (ROE) 6.1% 0.4%
4. Balance Sheet & Cash Flow CRON
Cash Generation (TTM) $65M -$12M
Cash Flow Margin 31.6% -22.1%
Net Cash / Leverage $410M Net Cash $116M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CRON
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 45.3% (20th %ile) 94.8% (6th %ile)
Put/Call OI Skew 0.01x (Call-Skewed) 0.50x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat CRON
OpEx & R&D Intensity 40.2% of Rev ($83M) 37.6% of Rev ($20M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Drug Manufacturers - Specialty & Generic Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRON (9) vs SIGA (1)
Institutional Metric CRON SIGA Criterion Row Edge
Market Capitalization
Scale
$1.1B $188.3M Larger Scale CRON
Trailing P/E Ratio
Valuation
19.2x N/M Lower Multiple CRON
Forward P/E Ratio
Valuation
12.0x 2.3x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
+74.6% -49.7% Higher Growth CRON
Operating Margin (TTM)
Profitability
6.1% -14.2% Higher Margin CRON
Net Profit Margin
Profitability
28.0% 1.3% Higher Margin CRON
Return on Equity (ROE)
Capital Efficiency
6.1% 0.4% Higher ROE CRON
52-Week Range Position
Momentum
47% ($2–$4) 2% ($2–$7) Stronger Trend CRON
Beta / 30D Volatility
Risk Regime
0.36β · 38% Vol 0.90β · 74% Vol Lower Realized Risk CRON
Unified Institutional Score
Composite Signal
53.4 / 100 (HOLD) 46.2 / 100 (HOLD) Higher Composite CRON
Trailing 12M Revenue (USD)
Operating Scale
$206M $52M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
46.3% 23.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.5x EV/Rev 3.37x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$65M ($410M Net Cash) -$12M ($116M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRON +12.05 pp
CRON: -11.76% · SIGA: -23.81%
3M Horizon CRON +7.52 pp
CRON: -10.85% · SIGA: -18.37%
6M Horizon CRON +59.67 pp
CRON: +10.95% · SIGA: -48.72%
1Y Horizon CRON +88.2 pp
CRON: +28.81% · SIGA: -59.39%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CRON Revenue SIGA Revenue CRON Op. Margin SIGA Op. Margin Margin Leader
FY2018 $10M $480M -168.7% 74.4% SIGA
FY2019 $20M $30M -645.5% -8.7% SIGA
FY2020 $50M $120M -469.6% 67.6% SIGA
FY2021 $60M $130M -452.2% 66.7% SIGA
FY2022 $90M $110M -128.4% 38.5% SIGA
FY2023 $90M $140M -97.2% 59.8% SIGA
FY2024 $120M $140M -65.1% 50.4% SIGA
FY2025 $150M $90M -11.9% 25.1% SIGA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRON CONSOLIDATION
61d in phase · OBV DISTRIBUTION
Current IV 45.3%
IV Percentile 20th %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact CRON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SIGA BREAKDOWN
34d in phase · OBV DISTRIBUTION
Current IV 94.8%
IV Percentile 6th %ile
Put/Call OI Skew 0.50x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRON Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $1.1B market capitalization and 6.1% operating margin.
OpEx & R&D Reinvestment 40.2% of Rev ($83M)
90D Engineering Disclosures 0 Published
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $188.3M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published

Investor FAQ CRON vs SIGA Key Questions & Quantitative Answers

As of Nov 20, 2026, Cronos Group Inc. Common Share (CRON) is the stronger overall head-to-head candidate over SIGA Technologies Inc. (SIGA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CRON carries a Unified Composite Score of 53.4/100 (HOLD) at $3.04 (12.0x Forward P/E, 6.1% operating margin), whereas SIGA carries 46.2/100 (HOLD) at $2.40 (2.3x Forward P/E, -14.2% operating margin). Technical & Structure Timing Caution: CRON trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 33.9); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CRON leads the Growth & Scale pillar: CRON posts +74.6% YoY revenue growth and -44.7% YoY earnings growth on $206M TTM revenue (46.3% gross margin, 6.1% operating margin), compared with SIGA at -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CRON cumulative revenue shifted +1400.0% while SIGA shifted -81.2%. In operating R&D and SG&A reinvestment, CRON deploys 40.2% of Rev ($83M) (0 90-day corporate R&D disclosures) versus 37.6% of Rev ($20M) (0 disclosures) for SIGA.

SIGA screens cheaper on headline valuation multiples. CRON trades at 12.0x Forward P/E, 19.2x Trailing P/E, N/M PEG, and 3.5x EV/Revenue (31.6% FCF margin), whereas SIGA trades at 2.3x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRON (6.1% ROE) versus SIGA (0.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CRON carries 45.3% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.36β · 38% Vol realized risk). By comparison, SIGA carries 94.8% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.50x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.90β · 74% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.